Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Segmentectomy for Ground Glass-dominant Invasive Lung Cancer With Size of 2-3cm: a Single-arm, Multi-center, Phase III Trial

NCT05717803 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT05717803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05717803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Segmentectomy for Ground Glass-dominant Invasive Lung Cancer With Size of 2-3cm: a Single-arm, Multi-center, Phase III Trial
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Recruiting
Start date
February 15, 2023
Completion date
December 31, 2029
Enrollment
307 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung adenocarcinoma, segmentectomy